Clinical trial
Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With…
NCT00196027 · Cierra, Industry · Unknown status
Key facts
| NCT number | NCT00196027 |
|---|---|
| Title | Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism |
| Official title | Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism |
| Lead sponsor | Cierra, Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Patent Foramen Ovale |
| Intervention type | Device |
| Interventions | PFX Closure System |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 29, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: